Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
This is a 25% decrease from the number of companies inspected in the previous quarter, when 12 companies received 12 inspections.
Most of the companies inspected at the time were involved in the Devices sector. Both the Biologics and Food and Cosmetics sectors sectors tied for second most common type.
There were eight companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct its management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
ADM | Food and Cosmetics | 07/12/2023 | No Action Indicated (NAI) |
Amar J. Gajjar, M.D. | Drugs | 07/21/2023 | No Action Indicated (NAI) |
Bionova Medical, Inc. | Devices | 09/29/2023 | No Action Indicated (NAI) |
Community Blood Center | Biologics | 08/02/2023 | No Action Indicated (NAI) |
Convatec Triad Life Sciences, LLC | Devices | 08/24/2023 | No Action Indicated (NAI) |
Creative Testing Solutions | Biologics | 09/26/2023 | No Action Indicated (NAI) |
Somavac Medical Solutions, Inc. | Devices | 09/22/2023 | Voluntary Action Indicated (VAI) |
Specialty Feeds, Inc. | Food and Cosmetics | 08/17/2023 | No Action Indicated (NAI) |
Specialty Feeds, Inc. | Veterinary | 08/17/2023 | No Action Indicated (NAI) |
Surface Dynamics, LLC | Devices | 09/21/2023 | No Action Indicated (NAI) |